Sobi co-founder thinks acquisition is likely after USD 8bn bid
Today’s takeover bid for Sobi is likely to end in deal that will create rapid growth, assesses co-founder, former CEO and previous chairman Bo Jesper Hansen.
BY ULRICH QUISTGAARD, TRANSLATED BY CATHERINE BRETT AND DANIEL INGEMANN KROIER PEDERSEN
Everything indicates that a bid of over USD 8bn (DKK 50bn) for Swedish Sobi from the American private equity firm Advent and Singapore's state private equity fund, GIC, through the joint company Agnafit Bidco, will end in an acquisition.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
FDA gives Saniona candidate priority status
For subscribers
Coloplast CEO struggling to find good acquisition candidate
For subscribers
